Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with a new kind of pump technology in the Twiist device.
NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...